Search research articles
Contact Us
Filters
Showing results (1-10 of 245) with videos related to
Page
of 25
Sort By:
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
August 11, 2001
Cyclin-dependent kinases inhibitors as potential anticancer, antineurodegenerative, antiviral and antiparasitic agents
Laurent Meijer
Medecine Sciences : M/S
|
June 11, 2004
[Mediterranean purple indirubins: a source of GSK-3 inhibitors]
Laurent Meijer
Biochemical Pharmacology
|
September 6, 2002
Identifying in vivo targets of cyclin-dependent kinase inhibitors by affinity chromatography
Marie Knockaert, Laurent Meijer
Accounts of Chemical Research
|
June 18, 2003
Roscovitine and other purines as kinase inhibitors. From starfish oocytes to clinical trials
Laurent Meijer, Eric Raymond
Biotechnology Journal
|
August 8, 2007
Editorial: role of cyclin-dependent kinase-5 (Cdk5) in the central nervous system
Marc Blondel, Laurent Meijer
Expert Opinion on Therapeutic Targets
|
February 15, 2007
Antimalarial drug discovery: targeting protein kinases
Christian Doerig, Laurent Meijer
Current Opinion in Cell Biology
|
September 10, 2013
Targeting cyclin-dependent kinases in anti-neoplastic therapy
Céline Bruyère, Laurent Meijer
International Journal of Molecular Sciences
|
July 2, 2021
Dual-Specificity, Tyrosine Phosphorylation-Regulated Kinases (DYRKs) and cdc2-Like Kinases (CLKs) in Human Disease, an Overview
Mattias F Lindberg, Laurent Meijer
Trends in Pharmacological Sciences
|
November 24, 2004
Pharmacological inhibitors of glycogen synthase kinase 3
Laurent Meijer, Marc Flajolet, Paul Greengard
Journal of Alzheimer'S Disease : JAD
|
October 18, 2024
Leucettinib-21, a DYRK1A Kinase Inhibitor as Clinical Drug Candidate for Alzheimer's Disease and Down Syndrome
Laurent Meijer, Emilie Chrétien, Denis Ravel
Page
of 25
Search research articles
Search
Showing results (1-10 of 245) with videos related to
Sort By:
Page
of 25
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
August 11, 2001
Cyclin-dependent kinases inhibitors as potential anticancer, antineurodegenerative, antiviral and antiparasitic agents
Laurent Meijer
Medecine Sciences : M/S
|
June 11, 2004
[Mediterranean purple indirubins: a source of GSK-3 inhibitors]
Laurent Meijer
Biochemical Pharmacology
|
September 6, 2002
Identifying in vivo targets of cyclin-dependent kinase inhibitors by affinity chromatography
Marie Knockaert, Laurent Meijer
Accounts of Chemical Research
|
June 18, 2003
Roscovitine and other purines as kinase inhibitors. From starfish oocytes to clinical trials
Laurent Meijer, Eric Raymond
Biotechnology Journal
|
August 8, 2007
Editorial: role of cyclin-dependent kinase-5 (Cdk5) in the central nervous system
Marc Blondel, Laurent Meijer
Expert Opinion on Therapeutic Targets
|
February 15, 2007
Antimalarial drug discovery: targeting protein kinases
Christian Doerig, Laurent Meijer
Current Opinion in Cell Biology
|
September 10, 2013
Targeting cyclin-dependent kinases in anti-neoplastic therapy
Céline Bruyère, Laurent Meijer
International Journal of Molecular Sciences
|
July 2, 2021
Dual-Specificity, Tyrosine Phosphorylation-Regulated Kinases (DYRKs) and cdc2-Like Kinases (CLKs) in Human Disease, an Overview
Mattias F Lindberg, Laurent Meijer
Trends in Pharmacological Sciences
|
November 24, 2004
Pharmacological inhibitors of glycogen synthase kinase 3
Laurent Meijer, Marc Flajolet, Paul Greengard
Journal of Alzheimer'S Disease : JAD
|
October 18, 2024
Leucettinib-21, a DYRK1A Kinase Inhibitor as Clinical Drug Candidate for Alzheimer's Disease and Down Syndrome
Laurent Meijer, Emilie Chrétien, Denis Ravel
Page
of 25